Scroll to top

Gendius technology for diabetes risk prediction launched in the GCC through new AstraZeneca patient support app, Health Gate

A new digital health platform which provides enhanced support to diabetes patients in the Gulf Cooperation Council (GCC) region ha...

4th May 2022

Gendius initiates GP data study to develop enhanced risk prediction tools for diabetes

UK medtech start-up Gendius has partnered with over 60 primary care practices on a data extraction study to develop enhanced risk ...

17th February 2022

DNA Weekly Feature - Identify Diabetes Risk Factors Early With Intellin Health Tracking App

We are so pleased to have an interview with Gendius's CEO and Co-Founder Rory Cameron featured on DNA Weekly! Take a look at a s...

Ditsa Keren From DNA Weekly 18th November 2021

Gendius to collaborate with The University of Manchester on New Human-AI Research Teams.

Gendius are proud to be a part of the new Human-AI research teams developed by the University of Manchester to help cure humanity'...

2nd August 2021

Gendius partners with digi.me to allow users to connect their health records to its smart diabetes management platform

British digital health start-up Gendius is partnering with digi.me to allow users to connect their health records to its smart dia...

22nd July 2020

Supporting industry-led innovations into the healthcare system

Daniel Zamora, Health Innovation Manchester’s Commercial Programme Manager, explains how his role is supporting companies with hea...

Daniel Zamora 19th June 2019

Intellin - Diabetes management platform

Momentum funding enabled Gendius to conduct a final piece of market research for their innovative platform designed as the “ultima...

Chris Genders 30th November 2018